Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care
- 12 May 2003
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 55 (6) , 604-608
Abstract
Aims To determine if a gender or age bias exists in the prescription of important secondary preventive therapies for ischaemic heart disease in primary care.Methods We identified 15 590 patients with ischaemic heart disease on the basis that they received a prescription for nitrate therapy over a 1‐year period (September 1999 to August 2000) from the Eastern Region of the General Medical Services scheme in Ireland (population of 334 031), which provides free health service to those eligible patients in primary care. Odds ratios (OR) for the prescription of aspirin, β‐blockers, statins, calcium channel antagonists and ACE inhibitors in women and in those aged> 65 years were determined.Results Female patients were less likely to receive a prescription for a β‐blocker [OR = 0.84, 95% confidence interval (CI) = 0.79, 0.89, P < 0.001], aspirin (OR = 0.72, 95% CI = 0.67, 0.78, P < 0.001), and ACE inhibitors (OR = 0.83, 95% CI = 0.78, 0.89, P < 0.001) compared with their male counterparts. However, women were more likely to receive anxiolytic benzodiazepines (OR = 1.71, 95% CI = 1.59, 1.85, P < 0.001) compared with their male counterparts. Elderly patients (aged> 65 years) were less likely to receive aspirin (OR = 0.92, 95% CI = 0.85, 0.99, P < 0.001), β‐blocker (OR = 0.66, 95% CI = 0.62, 0.71, P < 0.001) and a statin (OR = 0.5, 95% CI = 0.46, 0.53, P < 0.001).Conclusions An age and gender bias exists in the prescription of important secondary preventive therapies in primary care that may lead to increased mortality from ischaemic heart disease in these groups.Keywords
This publication has 34 references indexed in Scilit:
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialThe Lancet, 2002
- Pharmacoepidemiology—an Irish perspectivePharmacoepidemiology and Drug Safety, 2001
- Joint British recommendations on prevention of coronary heart disease in clinical practice: summaryBMJ, 2000
- Rose Questionnaire Angina in Younger Men and WomenJournal of Clinical Epidemiology, 1999
- Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)The Lancet, 1994
- Gender in medical encounters: An analysis of physician and patient communication in a primary care setting.Health Psychology, 1994
- Gender in medical encounters: An analysis of physician and patient communication in a primary care setting.Health Psychology, 1994
- Risk factors and in-hospital course of first episode of myocardial infarction or acute coronary insufficiency in womenJACC, 1988
- PREVALENCE OF ANGINA AS ASSESSED BY A SURVEY OF PRESCRIPTIONS FOR NITRATESThe Lancet, 1988
- Patterns of coronary heart disease morbidity and mortality in the sexes: A 26-year follow-up of the Framingham populationAmerican Heart Journal, 1986